Bruck Kifle

Array ( [id] => 5936709 [patent_doc_number] => 20020061905 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Ethers of 7-desmethylrapamycin' [patent_app_type] => new [patent_app_number] => 09/956322 [patent_app_country] => US [patent_app_date] => 2001-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3560 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061905.pdf [firstpage_image] =>[orig_patent_app_number] => 09956322 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5936708 [patent_doc_number] => 20020061904 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-23 [patent_title] => 'Hydroxyesters of 7-desmethylrapamycin' [patent_app_type] => new [patent_app_number] => 09/955685 [patent_app_country] => US [patent_app_date] => 2001-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3729 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0061/20020061904.pdf [firstpage_image] =>[orig_patent_app_number] => 09955685 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1551066 [patent_doc_number] => 06399625 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => '1-oxorapamycins' [patent_app_type] => B1 [patent_app_number] => 09/954880 [patent_app_country] => US [patent_app_date] => 2001-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7065 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399625.pdf [firstpage_image] =>[orig_patent_app_number] => 09954880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1602794 [patent_doc_number] => 06432973 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-13 [patent_title] => 'Water soluble rapamycin esters' [patent_app_type] => B1 [patent_app_number] => 09/954782 [patent_app_country] => US [patent_app_date] => 2001-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4685 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/432/06432973.pdf [firstpage_image] =>[orig_patent_app_number] => 09954782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6756561 [patent_doc_number] => 20030004338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-02 [patent_title] => 'Process for the preparation of epothilone analogs' [patent_app_type] => new [patent_app_number] => 09/946721 [patent_app_country] => US [patent_app_date] => 2001-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6670 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20030004338.pdf [firstpage_image] =>[orig_patent_app_number] => 09946721 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1369312 [patent_doc_number] => 06566360 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-20 [patent_title] => '2-phenyl substituted imidatriazinones as phosphodiesterase inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/943530 [patent_app_country] => US [patent_app_date] => 2001-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30790 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 2532 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/566/06566360.pdf [firstpage_image] =>[orig_patent_app_number] => 09943530 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1113117 [patent_doc_number] => 06803364 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-10-12 [patent_title] => 'Il-5 inhibiting 6-azauracil derivatives' [patent_app_type] => B1 [patent_app_number] => 09/868384 [patent_app_country] => US [patent_app_date] => 2001-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12722 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/803/06803364.pdf [firstpage_image] =>[orig_patent_app_number] => 09868384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6568531 [patent_doc_number] => 20020165218 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Materials and methods to potentiate cancer treatment' [patent_app_type] => new [patent_app_number] => 09/941897 [patent_app_country] => US [patent_app_date] => 2001-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49890 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20020165218.pdf [firstpage_image] =>[orig_patent_app_number] => 09941897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1440615 [patent_doc_number] => 06495682 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-12-17 [patent_title] => 'Process for recovering caprolactam and steam' [patent_app_type] => B2 [patent_app_number] => 09/934679 [patent_app_country] => US [patent_app_date] => 2001-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4589 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/495/06495682.pdf [firstpage_image] =>[orig_patent_app_number] => 09934679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6083087 [patent_doc_number] => 20020082420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Bicyclic heterocycles, pharmaceutical compositions containing them, their use, and processes for preparing them' [patent_app_type] => new [patent_app_number] => 09/933597 [patent_app_country] => US [patent_app_date] => 2001-08-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23155 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20020082420.pdf [firstpage_image] =>[orig_patent_app_number] => 09933597 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1093159 [patent_doc_number] => 06825192 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-30 [patent_title] => 'Heterodiazinone derivatives' [patent_app_type] => B1 [patent_app_number] => 09/913444 [patent_app_country] => US [patent_app_date] => 2001-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23073 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/825/06825192.pdf [firstpage_image] =>[orig_patent_app_number] => 09913444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1460627 [patent_doc_number] => 06392037 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-21 [patent_title] => 'Process for the preparation of -caprolactam' [patent_app_type] => B1 [patent_app_number] => 09/925730 [patent_app_country] => US [patent_app_date] => 2001-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3419 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/392/06392037.pdf [firstpage_image] =>[orig_patent_app_number] => 09925730 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1236093 [patent_doc_number] => 06689802 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-02-10 [patent_title] => 'Polymorphs of an epothilone analog' [patent_app_type] => B2 [patent_app_number] => 09/925112 [patent_app_country] => US [patent_app_date] => 2001-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7445 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/689/06689802.pdf [firstpage_image] =>[orig_patent_app_number] => 09925112 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7406593 [patent_doc_number] => 20040024203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Benzodiazepine derivatives as inhibitors of gamma secretase' [patent_app_type] => new [patent_app_number] => 10/399231 [patent_app_country] => US [patent_app_date] => 2003-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12339 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20040024203.pdf [firstpage_image] =>[orig_patent_app_number] => 10399231 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6132085 [patent_doc_number] => 20020077486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Platelet ADP receptor inhibitors' [patent_app_type] => new [patent_app_number] => 09/920325 [patent_app_country] => US [patent_app_date] => 2001-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22326 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20020077486.pdf [firstpage_image] =>[orig_patent_app_number] => 09920325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1398750 [patent_doc_number] => 06531468 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-03-11 [patent_title] => 'Diazabicyclooctane derivatives and therapeutic uses thereof' [patent_app_type] => B2 [patent_app_number] => 09/920587 [patent_app_country] => US [patent_app_date] => 2001-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13367 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 253 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/531/06531468.pdf [firstpage_image] =>[orig_patent_app_number] => 09920587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6381433 [patent_doc_number] => 20020119964 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-29 [patent_title] => 'Homoiminopiperidinyl hexanoic acid inhibitors of inducible nitric oxide synthase' [patent_app_type] => new [patent_app_number] => 09/920612 [patent_app_country] => US [patent_app_date] => 2001-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16377 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20020119964.pdf [firstpage_image] =>[orig_patent_app_number] => 09920612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6096794 [patent_doc_number] => 20020052355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'Azabicycloalkane derivatives and therapeutic uses thereof' [patent_app_type] => new [patent_app_number] => 09/920500 [patent_app_country] => US [patent_app_date] => 2001-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23316 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20020052355.pdf [firstpage_image] =>[orig_patent_app_number] => 09920500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6291687 [patent_doc_number] => 20020055500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-09 [patent_title] => 'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting B-amyloid peptide release and/or its synthesis by use of such compounds' [patent_app_type] => new [patent_app_number] => 09/916440 [patent_app_country] => US [patent_app_date] => 2001-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 204266 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20020055500.pdf [firstpage_image] =>[orig_patent_app_number] => 09916440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6243517 [patent_doc_number] => 20020045747 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds' [patent_app_type] => new [patent_app_number] => 09/916282 [patent_app_country] => US [patent_app_date] => 2001-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 204759 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20020045747.pdf [firstpage_image] =>[orig_patent_app_number] => 09916282 [rel_patent_id] =>[rel_patent_doc_number] =>)